**Core tip:** Several studies have demonstrated that the incidence of colorectal cancer (CRC) is higher in African Americans than Caucasian Americans. Reasons for this racial disparity are unknown. The current study, for the first time, demonstrated that dysbiosis in the gut microbiome plays a determinant role in the racial disparity of CRC. Determining the influence of the microbiota on the risk of developing CRC will have a major impact on health, since early-stage CRC hinges on the ability to detect early pathological changes. Subsequent translational studies could also be developed to alter microbiota with medications or diet, thus reducing the risk of developing CRC.

INTRODUCTION
============

Colorectal cancer (CRC) is the second leading cause of cancer death in the United States, and several studies have demonstrated that African Americans (AAs) have the highest rate of CRC in the United States\[[@B1]-[@B6]\]. AAs have the highest incidence and death rates for CRC than Caucasian Americans (CAs), Hispanics and Asian/Pacific Islanders\[[@B7]\]. CRC typically correlates with age, reflecting a multistep progression from normal epithelium to carcinoma. However, a significant number of AAs are diagnosed with CRC at a younger age compared to CAs\[[@B8]-[@B11]\]. Genomic alterations in oncogenes and tumor suppressor genes drive the epithelial cell transformation to carcinoma - including the Apc/Wnt-β-catenin signaling pathway and the tumor suppressor gene Apc\[[@B12]-[@B14]\]. Previous studies have shown that microRNA drivers upregulated in AAs lead to an increased proportion of cancer stem cells in human colonic epithelial cells\[[@B15]\].

The human microbiome is at the interface of intrinsic and environmental factors - and abnormalities in the gut microbiome have been noted in patients with CRC\[[@B16]-[@B19]\]. The colonic microbiota is mostly bacteria consisting of approximately 10^3^ different microbial species\[[@B20]\]. Gut microbiota is essential in the maintenance of homeostasis, and it contributes to immune development, inhibits pathogen colonization, processes drug metabolites, metabolizes nutrients from the diet and also modulates their biological activities\[[@B10],[@B21]\]. Dysregulation of gut microbiota and a concomitant state of chronic inflammation and persistent activation of the host immune system have been implicated in the initiation and development of CRC\[[@B22]-[@B24]\].

One primary role of gut bacteria is to participate in the biotransformation of products in the gut, which include bile acids secreted from the liver. The gut microbiota may alter cancer susceptibility and has anti-cancer effect through the production of microbial secretory metabolites, such as short chain fatty acids (SCFAs), secondary bile acids (SBA), and trimethylamine N-oxide (TAMO)\[[@B25]-[@B28]\]. SBAs, deoxycholic acid (DCA) and lithocholic acid (LCA), are noted in particular for their carcinogenic activity\[[@B29]-[@B33]\]. Murine models have demonstrated that DCA shifts the microbiota community to dysbiosis and promotes intestinal tumorigenesis in Apc^min/+^ mice when DCA-treated fecal microbiota inoculated in one mouse is transferred to another\[[@B34]\].

Thus, multifactorial reasons underlie the racial disparity of CRC. The current investigation was aimed at studying microbial dysbiosis in the gut between AAs and CAs. In this pilot study, we investigate the diversity and abundance of specific gut microbes in colonic effluents using 16S rRNA gene community profiles in AAs and CAs and their possible role in increased incidence of CRC in AAs.

MATERIALS AND METHODS
=====================

Study subjects and collection of samples
----------------------------------------

In the current pilot investigation, 52 AA and 46 CA patients were recruited. The study was approved by the Institutional Review Boards and Committees of the John D. Dingell-Veterans Affairs Medical Center (JDD-VAMC) and Wayne State University School of Medicine. Patients excluded from the study were those with active malignant disease, inflammatory bowel disease, recent infection and those recently treated with antibiotics. In addition, patients with psychiatric or addictive disorder, hemorrhagic diathesis or on warfarin were excluded. General characteristics of study participants are the same as described in our earlier publication\[[@B15]\]. None of the patients were taking probiotics as supplements. General characteristics of each group of patients are presented in Table [1](#T1){ref-type="table"}.

###### 

General characteristics of African American and Caucasian American patients

  **Race**   **Gender**   **Age**   **Height (inches)**   **Weight (lbs)**   **Body mass index**   **Polyp**   **Adenoma**
  ---------- ------------ --------- --------------------- ------------------ --------------------- ----------- -------------
  AA         Male         65.2      70.4                  181                28.9                  4.6         3.8
  CA         Male         62.6      69.0                  194                31.0                  1.43        1.0

AA: African Americans; CA: Caucasian Americans.

Eligible study subjects were scheduled for an outpatient screening colonoscopy at the JDD-VAMC. All study subjects received standard colonoscopy purgative preparation. Briefly, patients were asked to stay on a clear liquid diet for 24 h and to take a preparation containing 15 mg Bisacodyl the morning prior to their colonoscopy. The patients were also instructed to split the dose (4 L) of poly-ethylene glycol solution (PEG) into a first half (2 L) the evening prior to colonoscopy, and to drink the second half (the remaining 2 L) 5 h prior to the procedure and to finish it 3 h prior to the procedure, regardless of appointment time (morning or afternoon). Colonic effluent was aspirated prior to the colonoscopy through the working channel of the endoscope, as reported earlier\[[@B15]\]. Additionally, 8 forceps biopsies were taken from macroscopically normal appearing colonic mucosa (\< 10 cm anal verge), as described previously\[[@B15]\].

DNA extraction for 16S rRNA gene microbial community profiling
--------------------------------------------------------------

Genomic DNA was extracted from colonic effluents using QIAamp DNA Stool Mini Kit (QIAGEN) according to the manufacturer's instructions. Purified DNA used for analysis of 16S rRNA community profiling was performed by LC Sciences (Houston, Texas). The V3 and V4 regions of the 16S rRNA gene were amplified to generate approximately 469 bp amplicons, automating cluster generation and sequencing on the MiSeq system. For data analysis, the merge paired-end reads from DNA fragments were analyzed using next generation sequencing FLASH (Fast Length Adjustment SHort reads) software, and raw sequencing data quality control was checked using FastQC software. Operational taxonomic units (OTUs) clustering was based on 97% sequence similarity using CD-HIT software. Microbial strain identification software Quantitative Insights Into Microbial Ecology (QIIME) was used for alpha diversity and beta diversity, visualization of high throughput microbial community, and for principal coordinates analysis. Ribosomal Database Project (RDP) classifier, Greengenes, NCBI 16SMicrobial (TUIT tool) and GraPhlAn software were used for taxonomic classification and circular taxonomic phylogenetic trees.

Genomic DNA isolation from colonic effluents and validation
-----------------------------------------------------------

Bacterial genomic DNA was isolated from colonic effluents using QIAamp DNA Stool Mini Kit (QIAGEN) according to the manufacturer's instructions. For real time PCR, DNA (40-50 ng) and appropriate blank were used for RT-PCR analysis in triplicate using the 2 × Power-Up SYBR Green PCR Master Mix (Applied Biosystems) and the ABI Prism 7500 sequence detection system. PCR consisted of 40 cycles of 95 °C for 10 min and then 95 °C for 15 s, 60 °C for 60 s. The primer sequences were used to evaluate the presence of specific types of bacteria. Ct values were utilized to assess the relative concentration of specific DNA for each sample as described by the manufacturer. Each sample ^ΔΔ^Ct values was calculated by normalizing to the CT value of total bacteria (Eubacteria). 16S rDNA served as an internal control and each value represented the mean of three replicates. All oligonucleotide primers were synthesized by Integrated DNA technology Inc. (Coralville, IA, United States). The primer set for each gene is listed in Table [2](#T2){ref-type="table"}.

###### 

List of primers for bacterial genes specific for family, genus and species

  **Bacterial gene**           **Forward primer (5'-3')**      **Reverse primer (5'-3')**          **Ref**.
  ---------------------------- ------------------------------- ----------------------------------- ------------
  *Clostridium* cluster XI     TGACGGTACYYNRKGAGGAAGCC         CTACGGTTRAGCCGTAGCCTTT              \[[@B63]\]
  *Clostridium* cluster XIVa   GCGGTRCGGCAAGTCTGA              CCTCCGACACTCTAGTMCGAC               \[[@B64]\]
  *Clostridium* cluster IV     GCACAAGCAGTGGAGT                CTTCCTCCGTTTTGTCAA                  \[[@B65]\]
  *Bifidobacterium* genus      GATTCTGGCTCAGGATGAACGC          CTGATAGGACGCGACCCCAT                \[[@B66]\]
  *Lactobacillus* spp.         AGCAGTAGGGAATCTTCCA             CACCGCTACACATGGAG                   \[[@B66]\]
  *Enterobacter* (Family)      CATTGACGTTACCCGCAGAAGAAGC       CTCTACGAGACTCAAGCTTGC               \[[@B66]\]
  *Fusobacterium* (genus)      GGATTTATTGGGCGTAAAGC            GGCATTCCTACAAATATCTACGAA            \[[@B67]\]
  *Fusobacterium nucleatum*    CAACCATTACTTTAACTCTACCATGTTCA   GTTGACTTTACAGAAGGAGATTATGTAAAAATC   \[[@B68]\]
  *Clostridium sordelli*       CTGAGACACGTCCAAACTCTAC          CCTCCTCAAGTACCGTCATTATC             \-
  Total bacteria               CGTGCCAGCAGCCGCGG               TGGACTACCAGGGTATCTAATCCTG           

Real-Time PCR from biopsy
-------------------------

To determine the specific bacterial abundance between serrated and tubular adenomatous patients, total RNA was prepared from patient biopsy samples using TRIzol as recommended by the manufacturer and purified using the Rneasy Mini Kit (QIAGEN). For real time PCR, cDNA was prepared with the SuperScript III First-Strand cDNA synthesis system for RT-PCR (Invitrogen) and analyzed in triplicate using the 2 × Power-Up SYBR Green PCR Master Mix (Applied Biosystems) and the ABI Prism 7500 sequence detection system. Primers and PCR were performed as described in the previous section.

For determination of RT-PCR expression of 7-α-dehydroxylase (BaiCD), primers were as follows, *baiCD* forward: 5'-GGWTTCAGCCCRCAGATGTTCTTTG-3'; reverse: 5'GAATTCCGGGTTCATGAACATTCTKCKAAG-3'\[[@B35]\].

Statistical analysis
--------------------

For microbiota data statistical analysis, Metastats software was used for metagenomics sequencing data analyzed from two groups to characterize the microbial communities. CD-HT and R statistical software was used for BIOM-formatted OTU communities clustering and OTU statistics. For examining alpha diversity, QIIME software was used for graphics and statistical purposes. RDP classifier, QIIME, TUIT GraPhlAn, MetaPhlAn, R software/Too were used for taxonomic classification and statistics. For Real Time PCR data, the standard deviation of mean between two groups and t-test were performed to determine the significance level between two groups.

RESULTS
=======

Phylogenetic analysis of microbial communities in colonic effluents
-------------------------------------------------------------------

Microbiota composition of colonic effluent was compared by high throughput analysis of 16S small ribosomal subunit gene (16S rRNA) amplicon. Sequencing of the V3 + V4 region was used for OTU clustering based on 97% sequence similarity. We found unique OTUs in AAs (7234) and CAs (5252), with an overlap of 742 OTUs between the two groups (Figure [1A](#F1){ref-type="fig"}). We found higher species richness and species diversity in CAs using the number of OTUs in Shannon index (Figure [1B](#F1){ref-type="fig"}). Irrespective of high inter-individual variances, the Principal Coordinates Analysis (PCoA) showed AAs to possess an abundance of common microbiota, compared to dispersed CA counterparts, revealing more microbial homogeneity within AAs than CA patients (Figure [1C](#F1){ref-type="fig"}).

![Microbial diversity in colonic effluent from African Americans and Caucasian Americans. A: Venn diagram showing the unique Operational taxonomic units (OTUs) in different subsets of African American (AA) and Caucasian Americans (CA) including overlap community; B: Rarefaction curves showing the species richness from the average number of OTUs for AA and CA (alpha diversity); C: Principal coordinates analysis for beta diversity showing the very dissimilar individual in the CA group while closely similar to the group indicated by the yellow circle. CD-HIT and R software were used for BIOM format OTU clustering and OTU statistics. For measurement of alpha diversity of observed species, QIIME software and Shannon index were used and the emperor tool generated the PCoA plot.](WJGP-9-47-g001){#F1}

The microbiota composition of AAs and CAs showed significant differences in the *Bacteroidetes* and *Proteobacteria* phyla (Figure [2A](#F2){ref-type="fig"} and Table [3](#T3){ref-type="table"}). Taxonomic phylum from 11 from AAs and 24 from CAs were identified (Figure [2A](#F2){ref-type="fig"}). *Bacteroidetes* was the most abundant bacterial phylum in AAs (70%), whereas *Firmicutes* occurrence of 36% was higher in CAs (Figure [2A](#F2){ref-type="fig"}). Phylogenetic analysis further identified 44 classes of microbiota, with CAs showing more diverse population than AAs (Figure [2B](#F2){ref-type="fig"}). *Bacteroidia* was significantly higher in AAs, while *Clostridia, Bacteria-unclassified, Gammaproteobacteria, Bacilli, Verrucomicrobiae, Acinobacteria, Fusobacteria* and *Alphaproteobacteria* were more abundant in CAs (Figure [2B](#F2){ref-type="fig"}). Again, the microbial species richness and diversity was higher in CAs compared to AAs (Figure [2B](#F2){ref-type="fig"}).

![Microbial composition of each group at the phylum and class levels. A: Bar chart shows the relative abundance of phylum; B: Pie chart show the proportion of predominant different classes of microbial community in African Americans and Caucasian Americans. In order to get more comprehensive and accurate taxonomies, multiple databases, Ribosomal Database Project classifier, Greengenes and NCBI 16S Microbial were used for analysis of plot bars and pie charts.](WJGP-9-47-g002){#F2}

###### 

Abundance of microbiota in colonic effluents from African Americans and Caucasian Americans (green, black, blue and red color represent phylum, family, genus and species, respectively)

  **Phylum**                  **Family**              **Genus**               **Species**        **AA (%)**             **CA (%)**
  --------------------------- ----------------------- ----------------------- ------------------ ---------------------- ----------------------
  Bacteroidetes                                                                                  70.74                  43.17
                              Bacteroidaceae                                                     56.75                  29.94
                                                      Bacteroides                                56.8                   29.9
                                                                              Unclassified       30.3                   17.8
                                                                              Caccae             13.6                   5.5
                                                                              Massiliensis       6.7                    1.7
                                                                              Uniformis          2.8                    1.5
                                                                              Fragilis           1                      2
                              Rikenellaceae                                                      6.44                   5.47
                                                      Allistipes              Putredinis         6.4 (3.9)              5.4 (3.0)
                              Porphymonadaceae                                                   6.4                    6.95
                                                      Parabacteroides         Distasonis         4.9 (3.4)              3.2 (1.0)
                                                      Barnesiella             Intestinihominis   0.16 (0.16)            2.7 (2.6)
                              Prevotellaceae                                                     1.9                    1.1
                                                      Paraprevotella          Clara              1.0 (0.9)              0.6 (0.6)
  Firmicutes                                                                                     26.74                  36.25
                              Ruminococaceae                                                     11.35                  15.7
                                                      Faecalibacterium        Prausinitzii       4.5 (4.5)              3.1 (3.1)
                                                      Unclassified            Unclassified       2.5 (2.5)              2.9 (3.0)
                                                      Gemmiger                Formicilis         1.9 (1.6)              6.1 (6.0)
                                                      Clostridium IV          Unclassified       0.3 (0.3)              1.5 (1.5)
                              Lachnospiraceae                                                    11.19                  13.7
                                                      Ruminococcus 2          Unclassified       3.4 (3.4)              4.7 (4.7)
                                                      Clostridium XIVa        Unclassified       2.05 (2.0)             1.03 (1.0)
                                                      Unclassified            Unclassified       1.6 (1.7)              2.4 (2.4)
                                                      Blautica                Producta           0.22 (0.06)            1.2 (0.0)
                                                      Dorea                   Unclassified       1.8 (0.8)              1.3 (1.0)
                                                      Roseburia               Unclassified       0.5 (0.3)              1.3 (0.9)
                              Steptococaccae          Steptococcus            Faecium            0.9 (0.9) (0.8)        3.2 (3.2) (3.2)
                              Acidaminococcaceae      Phascolarctobacterium   Unclassified       1.8 (1.9) (1.4)        0.9 (0.9) (1.3)
                              Peptostreptococcaceae   Clostridium XI          Unclassified       0.02 (0.02) (0.02)     0.01 (0.008) (0.008)
                              Veillonellaceae         Veillonella             Atypica            0.81 (0.03) (0.03)     1.27 (0.02) (0.02)
                                                                              Unclassified       0.6 (0.6)              0.5 (0.5)
                                                      Dialister               Invisus            0.002 (0.0)            0.68 (0.65)
                              Lactobacillaceae        Lactobacillus           Sanfrancisecnsis   0.035 (0.02) (0.004)   0.01 (0.01) (0.001)
  Proteobacteria                                                                                 2.02                   5.9
                              Desulfovibrionaceae     Biophila                Unclassified       0.16 (0.12) (0.12)     0.07 (0.07) (0.01)
                              Sutterrellaceae         Parasuttrella           Excrementihomis    0.50 (0.76) (0.4)      0.24 (1.9) (0.1)
                              Pasteurellaceae         Haemophilus             Parainfluenza      0.57 (0.9) (0.4)       1.98 (1.9) (1.9)
                              Enterobacteiaceae       Escherichia/Shigella    Unclassified       0.92 (0.8) (0.9)       3.14 (3.1) (3.1)
                                                      Klebsiella              Unclassified       (0.09) (0.02)          0.003 (0.01)
  Fusobacteria                                                                                   0.18                   0.58
                              Fusobactereaceae        Fusobacterium           Unclassified       0.18 (0.15) (0.15)     0.58 (0.6) (0.6)
  Verrucomicrobia                                                                                0.04                   1.9
                              Verrucomicrobiaceae     Akkermansia             Muciniphila        0.04 (0.04)            1.9 (1.9)
  Bacteria-unclassified       Unclassified            Unclassified            Unclassified       0                      5.4 (5.4) (5.4)
  Unclassified-unclassified   Unclassified            Unclassified            Unclassified       0                      4.6 (4.6) (4.6)

AA: African Americans; CA: Caucasian Americans.

By 16S rRNA gene profiling, there were eight predominant families found between the two racial groups, *Bacteroidaceae*, *Ruminococcaceae*, *Lachnospiraceae*, *Rikenallaceae, Porphymonadaceae, streptococaceae, Acidaminococaceae and Veillonellaceae* (Table [3](#T3){ref-type="table"}). The most predominant genus in AAs and CAs was *Bacteroides*, comprising 56% and 29%, respectively. Genus abundance of other microbiota was less than 7% with some degree of variation, as observed for *Gemmiger, Allistipes, Parabacterroides, Faecalibacterium, Biophila, Ruminococcus2, Escherichia/Shigella (E/S), Streptococcus, Clostridium IV, Clostridium XIVa, Barnesiella, Akkermansia, Phascolartobacterium, Veillonella, Blautica, Roseburia, Haemophilus, Dialister* and *Fusobacterium* (Table [3](#T3){ref-type="table"}).

At the species levels, the relative abundance of *B. caccae* and *B. massiliensis, P. distasonis, P. unclassified, Biophila unclassified* and *Clostridium XI unclassified* were noted to be significantly higher in AAs compared to CAs (Table [3](#T3){ref-type="table"}). In CA, the abundance of *G. formicilis, Clostridium IV, B. intestinihominis, E/S. unclassified, H. parainfluenza, A. muciniphila, D. invisus, S. faecium* and *F. unclassified* abundance was higher than AA patients. However, with respect to *F. prausnitzii, Ruminococcus2 unclassified, A. putredinis*, and *P. clara*, the relative abundance was found to be similar in both groups (Table [3](#T3){ref-type="table"}). On the other hand, the *Fusobacterium* genus was higher in CAs compared to AAs (Figure [3A](#F3){ref-type="fig"}), and the *Fusobacterium* species level was identified as unclassified by microbial 16sRNA gene profiling.

![Abundance of inflammatory and probiotic bacteria in colonic effluent from two racial groups using RT-PCR. A: Genus, *Fusobacterium* occurrence higher in Caucasian American (CA); B: The relative abundance of pro-inflammatory *Enterobacter* occurrence is higher in African Americans (AAs); C and D: Probiotic *Bifidobacteria* and *A. muciniphila* is higher in CAs; E: Relative abundance of *F. nucleatum* is higher in AAs than CAs. Data represent mean ± SD of all samples from each group (^b^*P* \< 0.001).](WJGP-9-47-g003){#F3}

To further compare the microbial population between AAs and CAs, we examined the abundance of specific bacterial populations using species-specific primers. The occurrence of the *Enterobacter* genus was found to be considerably higher in AAs than CAs (Figure [3B](#F3){ref-type="fig"}), while the *Enterobacteriaceae* family showed the opposite pattern (Table [3](#T3){ref-type="table"}). Taxonomic analysis showed CAs to contain *Citrobacter, Klebsiela Escherichia coli, Enterobacter and Shigella sp*. (Table [3](#T3){ref-type="table"}). In contrast, the relative abundance of the probiotic bacteria genuses *Bifidobacterium* and *Akkermansia muciniphila* was considerably lower in AAs compared to CAs (Figures [3C](#F3){ref-type="fig"} and D). These observations demonstrate that the population of pro-inflammatory bacteria is higher in the gut of AAs than CAs.

Occurrence of Fusobacterium nucleatum and Clostridium genus
-----------------------------------------------------------

The relative abundance of *Fusobacterium nucleatum* has been associated with the development and progression of CRC\[[@B23],[@B36],[@B37]\]. We found that the relative abundance of *F. nucleatum* in colonic effluents was significantly higher in AAs than CAs (Figure [3E](#F3){ref-type="fig"}), indicating a greater risk for the development of CRC in AAs. On the other hand, serrated polyps, which supposedly possess a greater risk of developing CRC, did not exhibit an increased abundancy of *F. nucleatum*. In fact, we found the relative abundance of *F. nucleatum* to be higher in tubular adenoma than serrated adenoma (B-Raf proto oncogene, serine/threonine kinase (BRAF) mutation), whereas the probiotic *Lactobacillus* was lower in both serrated and tubular adenomas than those without adenoma (Figure [4](#F4){ref-type="fig"}). Likewise, the relative abundance of *Bifidobacteria* was found to be lower in tubular adenoma than those without adenoma (Figure [4](#F4){ref-type="fig"}).

![Abundance of probiotic and pro-carcinogenic bacteria in serrated and tubular adenomatous in colonic mucosa. African American and Caucasian American patients were combined. Data represent mean ± SD of all samples from each group (^a^*P* \< 0.05, ^b^*P* \< 0.001).](WJGP-9-47-g004){#F4}

Using a clostridium cluster analysis and RT-PCR, we found that the relative abundance of *Clostridium IV* was higher in CAs (Figure [5A](#F5){ref-type="fig"}), while *Clostridium XI* was significantly higher in AAs (Figure [5B](#F5){ref-type="fig"}). *Clostridium IV* is known to be mediate anti-inflammatory effects\[[@B38]-[@B40]\]. *Clostridium sordelli* in the *Clostridium XI* cluster group is known to transform SBA\[[@B41]\]. AA patients also showed higher concentrations of *C. sordelli*, compared to CAs (Figure [5C](#F5){ref-type="fig"}). A few species of gut anaerobes in the *Clostridium* genus promote the biotransformation of primary to SBA. Given the role of SBA (DCA and LCA) in promoting CRC, the expression of 7-α-dehydroxylase, an enzyme that participates in de-conjugation of primary bile acids, was examined. We found the expression of 7-α-dehydroxylase (baiCD) in colonic effluent from AA patients to be markedly higher than CA subjects (Figure [5D](#F5){ref-type="fig"}).

![Expression of secondary bile acids transforming enzyme 7-α-DH in the colonic effluent from African Americans and Caucasian Americans using RT-PCR. A: Distribution of different *Clostridium* cluster between African Americans (AA) and Caucasian Americans (CA); B: *Clostridium XI* expression was higher in AAs; C: Secondary bile acids transforming bacteria *Clostridium sordelli* was higher in AAs than CAs; D: Increased 7α-DH expression in AAs. Data represent mean ± SD of all samples from each group (^a^*P* \< 0.05, ^b^*P* \< 0.01).](WJGP-9-47-g005){#F5}

DISCUSSION
==========

Our pilot study comparing AA and CA gut microbiota from colonic effluents reveal three major differences between the groups: the AA gut microbiota was less diverse overall, AAs had more pro-inflammatory gut bacteria, and AAs had fewer anti-inflammatory gut bacteria. The phylogenetic tree of microbiota between AAs and CAs reveal an abundance of taxon in CA *vs* AA (Figure [6](#F6){ref-type="fig"}). Analyzing PCoA of patients, we noted trends found previously in comparing normal colon to adenomas and CRC\[[@B36],[@B42],[@B43]\]. Patients with colonic adenoma typically demonstrate reduced species richness and diversity compared to those without adenomas\[[@B44],[@B45]\]. Furthermore, a fecal microbiota shift occurs in patients with adenomas\[[@B46]\], and they exhibit increased diversity in mucosa than those without adenoma\[[@B47]\].

![Phylogenetic tree showing the differences and abundance of taxa in African Americans and Caucasian Americans colonic effluents. The taxon size and color indicate the relative abundance of family. GraPhlAn software was used for taxonomic classification and circular taxonomic phylogenetic trees and Ribosomal Database Project classifier, Quantitative Insights into Microbial Ecology, R software/Tool were used for taxonomic data analysis.](WJGP-9-47-g006){#F6}

The human gut microbiota composition is generally represented by three primary phyla: *Firmicutes* (30%-50%), *Bacteroidetes* (20%-40%), and *Actinobacteria* (1%-10%)\[[@B22]\]. The two predominant bacterial phyla, *Bacteroidetes*, and *Firmicutes*, which contribute to 95% of the total GI ecosystem, are associated with adenomas and CRC\[[@B48]\]. The abundance of phylum *Bacteroidetes (P. distasonis, Alistipes spp.)* in the gut may increase the rate of tumorigenesis\[[@B49]\]. Our current study demonstrates an abundance of *Bacteroidetes* (70%) and reduction in *Firmicute* and *Actinobacteria* in AAs, whereas the microbial balance between predominant groups was unchanged in CAs, as has been demonstrated previously\[[@B22]\]. These observations are similar to what Hester et al\[[@B50]\] noted in their investigation in that the *Firmicutes/Bacteroidetes* ratio is higher in AAs compared to CAs. There is also a relative abundance of *B. massiliensis* in AAs compared to CAs. CRC has also been shown to be associated *F. nucleatum* and pro-inflammatory bacteria, *Enterobacter* and *Clostridium XI-*species. *F. nucleatum* strains have been shown to promote carcinogenesis and invasion of host cells and potentiate tumorigenesis in mouse model of colon cancer\[[@B23],[@B37]\]. CRC patients demonstrate a higher abundance of *F. nucleatum* and *Clostridium difficile*, a member of *Clostridium XI*\[[@B51],[@B52]\]. Others have demonstrated that the relative increase in *Clostridium cluster XI* and *Enterobacteriaceae* are associated with intestinal dysbiosis\[[@B53]\].

Previous studies have suggested that a decrease in commensal microbiota in AAs may contribute to the tumorigenic microenvironment and that dysbiosis of gut microbiota may be partially responsible for promoting CRC and colitis-associated CRC\[[@B22],[@B42],[@B54]\]. In line with these observations, we found commensal bacteria *B. fragilis* to be slightly higher in CAs than AAs. *Bacteroides fragilis* is an immunomodulatory bacteria, which stimulates anti-inflammatory cytokine IL10 by Foxp3+ regulatory CD+ T (Treg) cells and suppresses mucosal inflammation\[[@B55],[@B56]\]. In contrast, *Unclassified-Bacteria* and *Unclassified-Unclassified* micro-organisms were only present in CAs *A. municiphila*, a member of *Verrumicomicrobia*, is an intestinal symbiont and is known to induce an anti-inflammatory effect and enhance immune function\[[@B57]\]. Depletion of *A. muciniphila* is associated with a variety of diseases, including diabetes\[[@B58],[@B59]\]. We found the relative abundance of *A. muciniphila* to be lower in AAs than their CA counterparts. Collectively, AAs have fewer bacterial populations that are known to suppress inflammation, improve mucus barrier function, and diminish permeability\[[@B60]\].

Human genetic variants can modulate the effects of the microbiome composition, and both are associated with many human complex diseases\[[@B61]\]. Microbiota changes with diet and stimulatory agents and can modulate disease development and progression\[[@B61],[@B62]\]. Microbial dysbiosis in AAs may serve as a point for prevention and ultimately treatment of CRC. Identifying a microbial signature associated with CRC is complicated by many factors. This study was limited by focusing on a specific population with limited sample size and did not investigate dietary differences. However, there were significant differences between the colonic effluent microbiota of the AA and CA study groups - with less diversity of bacteria, greater abundance of pro-inflammatory bacteria, and reduced anti-inflammatory bacteria. Mechanisms for tumorigenesis may include bacteria that promote SBA transformation, as suggested by higher 7-α-dehydroxylase in the AA *vs* CA group. Further study is needed to evaluate the role of decreased diversity and structural imbalance in the colon microbial communities and the development of CRC.

ARTICLE HIGHLIGHTS
==================

Research background
-------------------

The incidence of colorectal cancer (CRC), the third most common malignancy, is not only higher among African Americans (AAs), but is also associated with higher mortality. In addition, AAs tend to be diagnosed with CRC at a younger age than Caucasian Americans (CAs) and exhibit worse prognoses than their CA counterparts. Despite this grim outlook, neither the extrinsic/intrinsic factor(s) nor the underlying molecular and/or biochemical mechanisms are fully understood. We hypothesize that imbalance in the gut microbiome between AAs and CAs results in alterations of metabolites, which changes symbiotic relationships and enhance gastrointestinal diseases, including CRC. A number of bacteria are known to promote carcinogenesis in the colon by altering gut microbial composition, which may play a major role in colorectal carcinogenesis.

Research motivation
-------------------

CRC is the third leading malignancy world-wide, affecting both males and females equally. It represents one of the most common cancers in the United States and is estimated to be the second and third leading cause of cancer-related deaths in men and women, respectively, in the United States. Several studies have also demonstrated that AAs have the highest rate of CRC than any other racial group in the USA, and also AA men are even more likely to die from CRC than AA women. With these grim statistics, it is important to gain a better understanding of the underlying mechanism(s), particularly the role of gut microbiota, in regulating racial disparity in colorectal carcinogenesis.

Research objectives
-------------------

The current investigation was aimed at studying microbial dysbiosis in the gut between AAs and CAs. The primary endpoint of this investigation was to determine whether the increased incidence of CRC in AAs could be attributed to alterations in gut microbiota. In this pilot study, we investigated the diversity and abundance of specific gut microbial communities in colonic effluents using 16S rRNA gene profiling in AAs and CAs and their possible role in the increased incidence of CRC in AAs.

Research methods
----------------

Male and female AA and CA patients, aged between 40 and 80 years, undergoing routine colonoscopy at the John D. Dingell VA Medical Center in Detroit were asked to participate. To determine the microbial diversity and the microbial richness in AAs and CAs, colonic effluent from each patient was used for DNA extraction and 16s RNA gene-based microbial community profiling which was performed and analyzed by LC Sciences (Houston, Texas, United States). The composition of OTU and alpha diversity was measured by Venn diagram and Rarefaction measurement method. The relative abundance of phylum and classes was depicted by bar and pie chart. The phylogenic tree was plotted for AA and CA to determine the relative abundance of family in microbial community. Several inflammatory and probiotic bacterial marker candidates such as *Enterobacteria, Bifidobacteria, Lactobacillus, Fusobacterium* and/or *Clostridium genus* and species-specific bacteria were identified by real-time qPCR using specific primers designed on the basis of conserved and variable region in bacterial 16S rRNA genes according to our standard protocol. Statistical analysis was performed for each experiment accordingly.

Research results
----------------

The relative abundance of *Fusobacterium nucleatum*, which has been associated with the development and progression of CRC, was found to be significantly higher in AAs than CAs, indicating a greater risk for the development of CRC in AAs. *Clostridium IV*, a known mediator of anti-inflammatory effects, was found to be higher in CAs than AAs.

Research conclusion
-------------------

The human colon harbors a complex microbial flora. Bacterial density in the human colon is among the highest found in nature, approaching 10^12^ bacteria/gm wet weight of feces. These bacteria are in a symbiotic relationship with the intestine, utilizing undigested nutrients as substrates and in return, produce various vitamins, amino acids, transform bile salts and assist in the maintenance of the intestinal barrier, and the appropriate immune response against pathogens. This homeostasis is altered in a state of dysbiosis, which is overgrowth of pathogenic bacteria that are normally inhibited by commensal bacteria. Our current investigation, for the first time, demonstrates microbial dysbiosis between AAs and CAs. This imbalance, we believe, is partially responsible for the racial disparity in CRC observed between AAs and CAs.

Research perspective
--------------------

Although numerous studies have demonstrated that the incidence of CRC is higher in AAs than CAs, the reasons for this racial disparity are not fully understood. Data generated from this investigation reveal a role for the gut microbiome in racial disparity. The precise mechanisms by which changes in gut microbiota would lead to an increase CRC in AAs remain unexplored. However, it is tempting to speculate that this dysbiosis or overgrowth of certain bacteria in the gut of AAs resulting in alterations in microbial metabolites, specifically deoxycholic acid and lithocholic acid, which are known for their co-carcinogenic activity, could induce the process(es) of carcinogenesis in the colon of AAs. However, the levels of microbial metabolites, including bile acids in AAs and CAs with and without adenomas have not determined. Moreover, no information is available whether the observed dysbiosis in AAs is due to changes in diet and/or lifestyle. Undoubtedly, further investigations are needed to gain a better and fuller understanding of the intrinsic and extrinsic factors that are critically involved in regulating racial disparity in CRC.
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